Tigris Pharma Raises $16 Million

Tigris Pharmaceuticals Inc., a Bonita, Fla.-based developer of cancer therapies, has raised around $16 million in Series B funding. NGN Capital led the deal, and was joined by Wexford Capital and Bushido Capital Partners. Riverbank Capital Securities acted as placement agent. www.tigrispharma.com